These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 18797861)
21. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers. Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478 [TBL] [Abstract][Full Text] [Related]
22. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Hevonoja T; Pentikäinen MO; Hyvönen MT; Kovanen PT; Ala-Korpela M Biochim Biophys Acta; 2000 Nov; 1488(3):189-210. PubMed ID: 11082530 [TBL] [Abstract][Full Text] [Related]
23. Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. Stefansson S; Chappell DA; Argraves KM; Strickland DK; Argraves WS J Biol Chem; 1995 Aug; 270(33):19417-21. PubMed ID: 7642623 [TBL] [Abstract][Full Text] [Related]
24. An apolipoprotein B100 mimotope prevents obesity in mice. Kim HJ; Lee HJ; Choi JS; Han J; Kim JY; Na HK; Joung HJ; Kim YS; Binas B Clin Sci (Lond); 2016 Jan; 130(2):105-16. PubMed ID: 26519425 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation. Ettelaie C; Wilbourn BR; Adam JM; James NJ; Bruckdorfer KR Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1784-90. PubMed ID: 10397699 [TBL] [Abstract][Full Text] [Related]
26. Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression. Vergès B; Duvillard L; Pais de Barros JP; Bouillet B; Baillot-Rudoni S; Rouland A; Petit JM; Degrace P; Demizieux L Diabetes Care; 2021 Apr; 44(4):1027-1037. PubMed ID: 33531418 [TBL] [Abstract][Full Text] [Related]
27. Structure of apolipoprotein B-100 in low density lipoproteins. Segrest JP; Jones MK; De Loof H; Dashti N J Lipid Res; 2001 Sep; 42(9):1346-67. PubMed ID: 11518754 [TBL] [Abstract][Full Text] [Related]
28. Preferred orientations of LDL in vitreous ice indicate a discoid shape of the lipoprotein particle. van Antwerpen R Arch Biochem Biophys; 2004 Dec; 432(1):122-7. PubMed ID: 15519303 [TBL] [Abstract][Full Text] [Related]
30. Evidence for lipid-dependent structural changes in specific domains of apolipoprotein B100. Chauhan V; Wang X; Ramsamy T; Milne RW; Sparks DL Biochemistry; 1998 Mar; 37(11):3735-42. PubMed ID: 9521692 [TBL] [Abstract][Full Text] [Related]
31. Associations between circulating IgG antibodies to Apolipoprotein B Hu W; Zhang X; Han Y; Wang Y; Lei M; Megson IL; Wei J; Jin Y Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30242056 [No Abstract] [Full Text] [Related]
32. [The role of oxidative processes in augmentation of atherogenity of low density lipoprotein particles]. Kumskova EM; Aksenov DV; Konovalova GG; Tikhaze AK; Lankin VZ Kardiologiia; 2012; 52(6):61-6. PubMed ID: 22839672 [TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100. Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411 [TBL] [Abstract][Full Text] [Related]
34. Platelet activation by the apoB/E receptor-binding domain of LDL. Relou AM; Gorter G; van Rijn HJ; Akkerman JW Thromb Haemost; 2002 May; 87(5):880-7. PubMed ID: 12038793 [TBL] [Abstract][Full Text] [Related]
35. Detection of apolipoprotein B100 early conformational changes during oxidation. Krisko A; Stjepanović G; Pifat G; Ruysschaert JM; Goormaghtigh E Biochim Biophys Acta; 2007 Nov; 1768(11):2923-30. PubMed ID: 17920034 [TBL] [Abstract][Full Text] [Related]
36. Three complementary techniques for the clarification of temperature effect on low-density lipoprotein-chondroitin-6-sulfate interaction. Cilpa-Karhu G; Lipponen K; Samuelsson J; Oörni K; Fornstedt T; Riekkola ML Anal Biochem; 2013 Dec; 443(2):139-47. PubMed ID: 24055620 [TBL] [Abstract][Full Text] [Related]
37. Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia. Ferchaud-Roucher V; Zair Y; Aguesse A; Krempf M; Ouguerram K J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32805740 [TBL] [Abstract][Full Text] [Related]